PRDM1 antibody
-
- Target See all PRDM1 Antibodies
- PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This PRDM1 antibody is un-conjugated
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC)
- Purification
- Protein G Chromatography
- Immunogen
- This PRDM1 / BLIMP1 antibody was raised against full-length recombinant human PRDM1 / BLIMP1 protein.
- Clone
- ROS195
- Isotype
- IgG1
- Top Product
- Discover our top product PRDM1 Primary Antibody
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Concentration
- 1 μg/μL
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
-
Avoid repeated freeze/thaw cycles and keep on ice when not in storage.
- Storage
- -20 °C
- Storage Comment
- Antibodies in solution can be stored at -20 °C for 2 years.
- Expiry Date
- 6 months
-
-
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas." in: The American journal of pathology, Vol. 173, Issue 1, pp. 242-52, (2008) (PubMed).
: "PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor." in: Blood, Vol. 111, Issue 7, pp. 3867-71, (2008) (PubMed).
: "Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma." in: Blood, Vol. 110, Issue 1, pp. 339-44, (2007) (PubMed).
: "PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma." in: Haematologica, Vol. 91, Issue 4, pp. 467-74, (2006) (PubMed).
: "[Malignant fibrous histiocytoma of soft tissues: early report of 10 cases]." in: Medicina clínica, Vol. 97, Issue 7, pp. 279, (1991) (PubMed).
: "
-
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas." in: The American journal of pathology, Vol. 173, Issue 1, pp. 242-52, (2008) (PubMed).
-
- Target
- PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))
- Alternative Name
- PRDM1 / BLIMP1 (PRDM1 Products)
- Synonyms
- GB11750 antibody, CG5249 antibody, Dmel\\CG5249 antibody, blimp-1 antibody, dBlimp-1 antibody, dBlimp1 antibody, Blimp-1 antibody, Blimp1 antibody, nrd antibody, prdm1 antibody, ubo antibody, wu:fb99c12 antibody, zgc:91885 antibody, MGC52536 antibody, PRDM1 antibody, blimp1 antibody, xblimp1 antibody, prdi-bf1 antibody, BLIMP1 antibody, PRDI-BF1 antibody, ZNFPR1A1 antibody, PR/SET domain 1 antibody, probable serine/threonine-protein kinase DDB_G0282963 antibody, CG5249 gene product from transcript CG5249-RF antibody, blimp-1 antibody, PR domain containing 1a, with ZNF domain antibody, PR domain 1 S homeolog antibody, B lymphocyte induced maturation protein 1 antibody, PR domain 1 antibody, PR domain containing 1, with ZNF domain antibody, PRDM1 antibody, LOC408295 antibody, Blimp-1 antibody, CpipJ_CPIJ007425 antibody, prdm1a antibody, prdm1.S antibody, prdm1 antibody, Prdm1 antibody
- Molecular Weight
- 77 & 95 kDa
- Gene ID
- 639
- Pathways
- Regulation of Muscle Cell Differentiation
-